Your browser doesn't support javascript.
loading
Antibody-mediated allograft rejection is associated with an increase in peripheral differentiated CD28-CD8+ T cells - Analyses of a cohort of 1032 kidney transplant recipients.
Mai, Hoa Le; Degauque, Nicolas; Le Bot, Sabine; Rimbert, Marie; Renaudin, Karine; Danger, Richard; Le Borgne, Florent; Kerleau, Clarisse; Tilly, Gaelle; Vivet, Anaïs; Delbos, Florent; Walencik, Alexandre; Giral, Magali; Brouard, Sophie.
Afiliación
  • Mai HL; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France.
  • Degauque N; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France.
  • Le Bot S; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France; Service de Néphrologie et Immunologie Clinique, CHU Nantes, Nantes, France.
  • Rimbert M; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France; Laboratoire d'Immunologie, Centre d'ImmunoMonitorage Nantes-Atlantique (CIMNA), CHU Nantes, Nantes, France.
  • Renaudin K; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France; Service d'Anatomie et Cytologie Pathologiques, CHU Nantes, Nantes, France.
  • Danger R; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France.
  • Le Borgne F; IDBC-A2COM, Nantes, France; INSERM UMR 1246 - SPHERE, Nantes, France.
  • Kerleau C; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France.
  • Tilly G; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France.
  • Vivet A; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France.
  • Delbos F; Etablissement Français du Sang (EFS), Nantes, France.
  • Walencik A; Etablissement Français du Sang (EFS), Nantes, France.
  • Giral M; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France; Service de Néphrologie et Immunologie Clinique, CHU Nantes, Nantes, France; Fondation Centaure (RTRS), Nantes, France. Electronic address: magali.giral@
  • Brouard S; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France; Fondation Centaure (RTRS), Nantes, France. Electronic address: sophie.brouard@univ-nantes.fr.
EBioMedicine ; 83: 104226, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35988467
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Antígenos CD28 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: EBioMedicine Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Antígenos CD28 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: EBioMedicine Año: 2022 Tipo del documento: Article País de afiliación: Francia